期刊文献+

高效液相色谱法测定人血浆氟比洛芬对映体浓度

Determination of enantiomers of flurbiprofen in plasma by HPLC
原文传递
导出
摘要 目的:建立用高效液相色谱法测定血浆氟比洛芬对映体浓度的方法。方法:本试验采用环己烷提取血浆样品中氟比洛芬,色谱柱为Chirobiotic V(250 mm×4.6 mm,5μm),流动相为甲醇-冰醋酸-三乙胺(100∶0.01∶0.01),检测波长为250 nm,内标为S-酮洛芬。结果:各组分之间没有干扰,分离度良好。血浆中R-氟比洛芬和S-氟比洛芬浓度在30~1 000 ng.mL-1范围内线性关系良好。两个对映体相对回收率分别为98.6%~100.2%和98.7%~101.2%,绝对回收率分别为76.1%~81.6%和76.6%~80.5%,日内RSD分别为3.9%~5.7%和4.1%~6.2%,日间RSD分别为5.8%~7.5%和6.1%~7.4%。结论:该方法操作快速简便,重现性好、灵敏度高,可满足血浆氟比洛芬对映体浓度测定及药代动力学研究的需要。 Objective:To establish a method for the determination of plasma levels of enantiomers of flurbiprofen.Methods:Flurbiprofen was extracted with cyclohexane.HPLC was performed on a Chirobiotic column with methanol-aceticacid-triethylamine(100∶0.01∶0.01)as mobile phase.Detection wavelength was 250 nm.S-Ketoprofen was used as the internal standard.Results:Under this chromatographic condition,R-flurbiprofen,S-flurbiprofen and S-Ketoprofen had no interference with each other.The calibration curve was linear in the range of 30-1 000 ng·mL^-1 for R-flurbiprofen and S-flurbiprofen.The relative recoveries of R-flurbiprofen and S-flurbiprofen were 98.6%-100.2% and 98.7%-101.2%,respectively.The absolute recoveries of R-flurbiprofen and S-flurbiprofen were 76.1%-81.6% and 76.6%-80.5%,respectively.The intraday RSDs were 3.9%-5.7% and 4.1%-6.2%,and interday RSDs were 5.8%-7.5% and 6.1%-7.4%,respectively.Conclusion:This method is rapid and simple,with high sensitivity and good repeatability,it can be used for the determination of flurbiprofen enantiomers in human plasma and their pharmacokinetic study.
出处 《中国新药杂志》 CAS CSCD 北大核心 2012年第21期2566-2568,2572,共4页 Chinese Journal of New Drugs
关键词 高效液相色谱法 氟比洛芬 手性固定相 对映体 血浆浓度 HPLC flurbiprofen chiral stationary phase enantiomers plasma concentration
  • 相关文献

参考文献8

  • 1OZBAY L. Clinical study on the bioequivalence of two tablet for- mulations of flurbiprofen [ J ]. Eur J Drug Metab Pharmacokinet, 2009,34(1):1-5.
  • 2YAN ML,GANG YL,YUN L,et al. Pharmacokinetic and bioequiv- alence comparison between orally disintegrating and conventional tablet formulations of flurbiprofen: A single-dose, randomized-se- quence ,open-label, two-period crossover study in healthy chinese male volunteers [ J ]. Clinical Therapeutics, 2009,31 ( 8 ) : 1787 - 1795.
  • 3WANG H, YUAN L, ZENG S. Characterizing the effect of UDP- glucuronosyhransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen [ J ]. Biochem Pharmacol, 2011,82 ( 11 ) : 1757 - 1763.
  • 4GEERTS H. Drug evaluation : (R) -flurbiprofen : an enantiomer of flurbiprofen for the treatment of Alzheimer's disease[J]. IDrugs, 2007,10 (2) :121 -133.
  • 5QAYYUM A. Determination of pharmacokinetics of flurbiprofen in Pakistani population using modified HPLC method [ J ]. J Chroma- togr Sci,2011,49(2) :108 - 113.
  • 6GHANEM A. Direct enantioselective HPLC monitoring of lipase- catalyzed kinetic resolution of flurbiprofen [ J ]. Chirality,2010,22 (6) :597 -603.
  • 7JENSEN BP, CHIN PK, BEGG E J, et al. Quantification of total and free concentrations of R- and S-warfarin in human plasma by ultrafiltr- ation and LC-MS/MS [ J ]. Anal Bioanal Chem, 2011, 401(7) :2187 -2193.
  • 8HASHEM H,TRUNDELBERG C. Effect of chromatographic con- ditions on liquid chromatographic chiral separation of terbutaline and salbutamol on Chirobiotic V column [ J ]. J Chromatogr A,2011,1218(38):6727 -6731.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部